These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2739882)

  • 21. Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
    Itoh T; Murai S; Masuda Y; Abe E; Ohkubo N; Itsukaichi O; Shoji S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):571-6. PubMed ID: 1438494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.
    Hirosue Y; Inui A; Miura M; Nakajima M; Okita M; Himori N; Baba S; Kasuga M
    Peptides; 1992; 13(1):155-7. PubMed ID: 1620653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.
    Zetler G
    Peptides; 1982; 3(4):701-4. PubMed ID: 6291014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feeding-suppressive mechanism of sulfated cholecystokinin (26-33) in chicks.
    Tachibana T; Matsuda K; Kawamura M; Ueda H; Khan MS; Cline MA
    Comp Biochem Physiol A Mol Integr Physiol; 2012 Apr; 161(4):372-8. PubMed ID: 22227312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
    Katsuura G; Itoh S; Rehfeld JF
    Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
    Rex A; Barth T; Voigt JP; Domeney AM; Fink H
    Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCK 8 analgesia and hyperalgesia after intrathecal administration in the rat: comparison with CCK-related peptides.
    Pittaway KM; Rodriguez RE; Hughes J; Hill RG
    Neuropeptides; 1987 Jul; 10(1):87-108. PubMed ID: 3670569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic projection to the central amygdala mediates the facilitatory effect of CCK-8US and caerulein on memory in rats.
    Winnicka MM; Wiśniewski K
    Pharmacol Res; 1999 Jun; 39(6):445-50. PubMed ID: 10373247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
    Weiss F; Tanzer DJ; Ettenberg A
    Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.
    Zetler G
    Peptides; 1984; 5(4):729-36. PubMed ID: 6093075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
    Kádár T; Borda L; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
    Männistö PT; Peuranen E; Harro J; Vasar E
    Neuropeptides; 1992 Dec; 23(4):251-8. PubMed ID: 1475033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
    Maurice T; Hiramatsu M; Kameyama T; Hasegawa T; Nabeshima T
    J Pharmacol Exp Ther; 1994 May; 269(2):665-73. PubMed ID: 8182534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
    Hagino Y; Moroji T
    Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.